Kite Pharma (KITE) Tops Q3 EPS by 51c

November 9, 2016 9:00 AM EST
Get Alerts KITE Hot Sheet
Trade KITE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Kite Pharma (NASDAQ: KITE) reported Q3 EPS of ($1.10), $0.51 better than the analyst estimate of ($1.61). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $4.94 million.

For earnings history and earnings-related data on Kite Pharma (KITE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment